Últimos Artículos de Lancet Diabetes & Endocrinology
- [Comment] 60 years on, growth hormone inches its way to safety
- [Editorial] EDCs: time to take action
- [Correspondence] Management of diabetes in patients with COVID-19
- [In Focus] Andrea Gore: neuroendocrinologist and environmental activist
- [Comment] Type 1 diabetes and fasting in Ramadan: time to rethink classification of risk?
- [Series] Endocrine-disrupting chemicals: implications for human health
- [Articles] Associations between androgens and sexual function in premenopausal women: a cross-sectional study
- [Comment] No more fracture trials in osteoporosis?
- [Articles] Long-term mortality after childhood growth hormone treatment: the SAGhE cohort study
- [Correspondence] Back to normal? Building community resilience after COVID-19
- [Correspondence] Metabolic health and COVID-19: a call for greater medical nutrition education
- [Articles] Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials
- [Correspondence] Management of diabetes in patients with COVID-19
- [Correspondence] Management of diabetes in patients with COVID-19
- [Correspondence] Management of diabetes in patients with COVID-19
- [Correspondence] Management of diabetes in patients with COVID-19 – Authors' reply
- [Series] Endocrine-disrupting chemicals: economic, regulatory, and policy implications
- [Correspondence] Management of diabetes in patients with COVID-19
- [Editorial] COVID-19 and Racism—a double edged dagger
- [Correspondence] COVID-19 pandemic highlights racial health inequities